The global Pet Disease Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Parasiticides Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Pet Disease Drugs include Merck & Co., Inc., Ceva, Vetoquinol S.A., Zoetis, Virbac, Bimeda, Calier, Boehringer Ingelheim and Elanco Animal Health, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
These drugs are used to quiet anxious pets or help in reducing anxiety associated with various behavioral issues in pets.
This report aims to provide a comprehensive presentation of the global market for Pet Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Disease Drugs. This report contains market size and forecasts of Pet Disease Drugs in global, including the following market information:
Global Pet Disease Drugs Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Pet Disease Drugs Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Pet Disease Drugs companies in 2023 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pet Disease Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pet Disease Drugs Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Pet Disease Drugs Market Segment Percentages, by Type, 2023 (%)
Parasiticides
Anti-infectives
Anti-inflammatory
Analgesics
Others
Global Pet Disease Drugs Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Pet Disease Drugs Market Segment Percentages, by Application, 2023 (%)
Infectious Diseases
Dermatologic Diseases
Pain
Orthopedic Diseases
Behavioral Diseases
Other
Global Pet Disease Drugs Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Pet Disease Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pet Disease Drugs revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Pet Disease Drugs revenues share in global market, 2023 (%)
Key companies Pet Disease Drugs sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Pet Disease Drugs sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck & Co., Inc.
Ceva
Vetoquinol S.A.
Zoetis
Virbac
Bimeda
Calier
Boehringer Ingelheim
Elanco Animal Health
Dechra Pharmaceuticals
Norbrook Laboratories
Chanelle Pharma
K-Laser USA
Assisi Animal Health
Multi Radiance Medical
Avazzia
SOUND Technologies
IRM Enterprises
Ashish Life Science
Century Pharmaceuticals
VETINDIA Pharmaceuticals
Ourofino Animal Health
SeQuent Scientific
LABINDIA Healthcare
Morvel Laboratories
Richter Pharma
Zuche Pharmaceuticals
Fidelis Animal Health
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pet Disease Drugs, market overview.
Chapter 2: Global Pet Disease Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Pet Disease Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pet Disease Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pet Disease Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pet Disease Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pet Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pet Disease Drugs Overall Market Size
2.1 Global Pet Disease Drugs Market Size: 2023 VS 2030
2.2 Global Pet Disease Drugs Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Pet Disease Drugs Sales: 2019-2030
3 Company Landscape
3.1 Top Pet Disease Drugs Players in Global Market
3.2 Top Global Pet Disease Drugs Companies Ranked by Revenue
3.3 Global Pet Disease Drugs Revenue by Companies
3.4 Global Pet Disease Drugs Sales by Companies
3.5 Global Pet Disease Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Pet Disease Drugs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Pet Disease Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pet Disease Drugs Players in Global Market
3.8.1 List of Global Tier 1 Pet Disease Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Pet Disease Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pet Disease Drugs Market Size Markets, 2023 & 2030
4.1.2 Parasiticides
4.1.3 Anti-infectives
4.1.4 Anti-inflammatory
4.1.5 Analgesics
4.1.6 Others
4.2 By Type - Global Pet Disease Drugs Revenue & Forecasts
4.2.1 By Type - Global Pet Disease Drugs Revenue, 2019-2024
4.2.2 By Type - Global Pet Disease Drugs Revenue, 2025-2030
4.2.3 By Type - Global Pet Disease Drugs Revenue Market Share, 2019-2030
4.3 By Type - Global Pet Disease Drugs Sales & Forecasts
4.3.1 By Type - Global Pet Disease Drugs Sales, 2019-2024
4.3.2 By Type - Global Pet Disease Drugs Sales, 2025-2030
4.3.3 By Type - Global Pet Disease Drugs Sales Market Share, 2019-2030
4.4 By Type - Global Pet Disease Drugs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pet Disease Drugs Market Size, 2023 & 2030
5.1.2 Infectious Diseases
5.1.3 Dermatologic Diseases
5.1.4 Pain
5.1.5 Orthopedic Diseases
5.1.6 Behavioral Diseases
5.1.7 Other
5.2 By Application - Global Pet Disease Drugs Revenue & Forecasts
5.2.1 By Application - Global Pet Disease Drugs Revenue, 2019-2024
5.2.2 By Application - Global Pet Disease Drugs Revenue, 2025-2030
5.2.3 By Application - Global Pet Disease Drugs Revenue Market Share, 2019-2030
5.3 By Application - Global Pet Disease Drugs Sales & Forecasts
5.3.1 By Application - Global Pet Disease Drugs Sales, 2019-2024
5.3.2 By Application - Global Pet Disease Drugs Sales, 2025-2030
5.3.3 By Application - Global Pet Disease Drugs Sales Market Share, 2019-2030
5.4 By Application - Global Pet Disease Drugs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Pet Disease Drugs Market Size, 2023 & 2030
6.2 By Region - Global Pet Disease Drugs Revenue & Forecasts
6.2.1 By Region - Global Pet Disease Drugs Revenue, 2019-2024
6.2.2 By Region - Global Pet Disease Drugs Revenue, 2025-2030
6.2.3 By Region - Global Pet Disease Drugs Revenue Market Share, 2019-2030
6.3 By Region - Global Pet Disease Drugs Sales & Forecasts
6.3.1 By Region - Global Pet Disease Drugs Sales, 2019-2024
6.3.2 By Region - Global Pet Disease Drugs Sales, 2025-2030
6.3.3 By Region - Global Pet Disease Drugs Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Pet Disease Drugs Revenue, 2019-2030
6.4.2 By Country - North America Pet Disease Drugs Sales, 2019-2030
6.4.3 US Pet Disease Drugs Market Size, 2019-2030
6.4.4 Canada Pet Disease Drugs Market Size, 2019-2030
6.4.5 Mexico Pet Disease Drugs Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Pet Disease Drugs Revenue, 2019-2030
6.5.2 By Country - Europe Pet Disease Drugs Sales, 2019-2030
6.5.3 Germany Pet Disease Drugs Market Size, 2019-2030
6.5.4 France Pet Disease Drugs Market Size, 2019-2030
6.5.5 U.K. Pet Disease Drugs Market Size, 2019-2030
6.5.6 Italy Pet Disease Drugs Market Size, 2019-2030
6.5.7 Russia Pet Disease Drugs Market Size, 2019-2030
6.5.8 Nordic Countries Pet Disease Drugs Market Size, 2019-2030
6.5.9 Benelux Pet Disease Drugs Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Pet Disease Drugs Revenue, 2019-2030
6.6.2 By Region - Asia Pet Disease Drugs Sales, 2019-2030
6.6.3 China Pet Disease Drugs Market Size, 2019-2030
6.6.4 Japan Pet Disease Drugs Market Size, 2019-2030
6.6.5 South Korea Pet Disease Drugs Market Size, 2019-2030
6.6.6 Southeast Asia Pet Disease Drugs Market Size, 2019-2030
6.6.7 India Pet Disease Drugs Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Pet Disease Drugs Revenue, 2019-2030
6.7.2 By Country - South America Pet Disease Drugs Sales, 2019-2030
6.7.3 Brazil Pet Disease Drugs Market Size, 2019-2030
6.7.4 Argentina Pet Disease Drugs Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pet Disease Drugs Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Pet Disease Drugs Sales, 2019-2030
6.8.3 Turkey Pet Disease Drugs Market Size, 2019-2030
6.8.4 Israel Pet Disease Drugs Market Size, 2019-2030
6.8.5 Saudi Arabia Pet Disease Drugs Market Size, 2019-2030
6.8.6 UAE Pet Disease Drugs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Merck & Co., Inc.
7.1.1 Merck & Co., Inc. Company Summary
7.1.2 Merck & Co., Inc. Business Overview
7.1.3 Merck & Co., Inc. Pet Disease Drugs Major Product Offerings
7.1.4 Merck & Co., Inc. Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.1.5 Merck & Co., Inc. Key News & Latest Developments
7.2 Ceva
7.2.1 Ceva Company Summary
7.2.2 Ceva Business Overview
7.2.3 Ceva Pet Disease Drugs Major Product Offerings
7.2.4 Ceva Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.2.5 Ceva Key News & Latest Developments
7.3 Vetoquinol S.A.
7.3.1 Vetoquinol S.A. Company Summary
7.3.2 Vetoquinol S.A. Business Overview
7.3.3 Vetoquinol S.A. Pet Disease Drugs Major Product Offerings
7.3.4 Vetoquinol S.A. Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.3.5 Vetoquinol S.A. Key News & Latest Developments
7.4 Zoetis
7.4.1 Zoetis Company Summary
7.4.2 Zoetis Business Overview
7.4.3 Zoetis Pet Disease Drugs Major Product Offerings
7.4.4 Zoetis Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.4.5 Zoetis Key News & Latest Developments
7.5 Virbac
7.5.1 Virbac Company Summary
7.5.2 Virbac Business Overview
7.5.3 Virbac Pet Disease Drugs Major Product Offerings
7.5.4 Virbac Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.5.5 Virbac Key News & Latest Developments
7.6 Bimeda
7.6.1 Bimeda Company Summary
7.6.2 Bimeda Business Overview
7.6.3 Bimeda Pet Disease Drugs Major Product Offerings
7.6.4 Bimeda Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.6.5 Bimeda Key News & Latest Developments
7.7 Calier
7.7.1 Calier Company Summary
7.7.2 Calier Business Overview
7.7.3 Calier Pet Disease Drugs Major Product Offerings
7.7.4 Calier Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.7.5 Calier Key News & Latest Developments
7.8 Boehringer Ingelheim
7.8.1 Boehringer Ingelheim Company Summary
7.8.2 Boehringer Ingelheim Business Overview
7.8.3 Boehringer Ingelheim Pet Disease Drugs Major Product Offerings
7.8.4 Boehringer Ingelheim Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.8.5 Boehringer Ingelheim Key News & Latest Developments
7.9 Elanco Animal Health
7.9.1 Elanco Animal Health Company Summary
7.9.2 Elanco Animal Health Business Overview
7.9.3 Elanco Animal Health Pet Disease Drugs Major Product Offerings
7.9.4 Elanco Animal Health Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.9.5 Elanco Animal Health Key News & Latest Developments
7.10 Dechra Pharmaceuticals
7.10.1 Dechra Pharmaceuticals Company Summary
7.10.2 Dechra Pharmaceuticals Business Overview
7.10.3 Dechra Pharmaceuticals Pet Disease Drugs Major Product Offerings
7.10.4 Dechra Pharmaceuticals Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.10.5 Dechra Pharmaceuticals Key News & Latest Developments
7.11 Norbrook Laboratories
7.11.1 Norbrook Laboratories Company Summary
7.11.2 Norbrook Laboratories Pet Disease Drugs Business Overview
7.11.3 Norbrook Laboratories Pet Disease Drugs Major Product Offerings
7.11.4 Norbrook Laboratories Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.11.5 Norbrook Laboratories Key News & Latest Developments
7.12 Chanelle Pharma
7.12.1 Chanelle Pharma Company Summary
7.12.2 Chanelle Pharma Pet Disease Drugs Business Overview
7.12.3 Chanelle Pharma Pet Disease Drugs Major Product Offerings
7.12.4 Chanelle Pharma Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.12.5 Chanelle Pharma Key News & Latest Developments
7.13 K-Laser USA
7.13.1 K-Laser USA Company Summary
7.13.2 K-Laser USA Pet Disease Drugs Business Overview
7.13.3 K-Laser USA Pet Disease Drugs Major Product Offerings
7.13.4 K-Laser USA Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.13.5 K-Laser USA Key News & Latest Developments
7.14 Assisi Animal Health
7.14.1 Assisi Animal Health Company Summary
7.14.2 Assisi Animal Health Business Overview
7.14.3 Assisi Animal Health Pet Disease Drugs Major Product Offerings
7.14.4 Assisi Animal Health Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.14.5 Assisi Animal Health Key News & Latest Developments
7.15 Multi Radiance Medical
7.15.1 Multi Radiance Medical Company Summary
7.15.2 Multi Radiance Medical Business Overview
7.15.3 Multi Radiance Medical Pet Disease Drugs Major Product Offerings
7.15.4 Multi Radiance Medical Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.15.5 Multi Radiance Medical Key News & Latest Developments
7.16 Avazzia
7.16.1 Avazzia Company Summary
7.16.2 Avazzia Business Overview
7.16.3 Avazzia Pet Disease Drugs Major Product Offerings
7.16.4 Avazzia Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.16.5 Avazzia Key News & Latest Developments
7.17 SOUND Technologies
7.17.1 SOUND Technologies Company Summary
7.17.2 SOUND Technologies Business Overview
7.17.3 SOUND Technologies Pet Disease Drugs Major Product Offerings
7.17.4 SOUND Technologies Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.17.5 SOUND Technologies Key News & Latest Developments
7.18 IRM Enterprises
7.18.1 IRM Enterprises Company Summary
7.18.2 IRM Enterprises Business Overview
7.18.3 IRM Enterprises Pet Disease Drugs Major Product Offerings
7.18.4 IRM Enterprises Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.18.5 IRM Enterprises Key News & Latest Developments
7.19 Ashish Life Science
7.19.1 Ashish Life Science Company Summary
7.19.2 Ashish Life Science Business Overview
7.19.3 Ashish Life Science Pet Disease Drugs Major Product Offerings
7.19.4 Ashish Life Science Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.19.5 Ashish Life Science Key News & Latest Developments
7.20 Century Pharmaceuticals
7.20.1 Century Pharmaceuticals Company Summary
7.20.2 Century Pharmaceuticals Business Overview
7.20.3 Century Pharmaceuticals Pet Disease Drugs Major Product Offerings
7.20.4 Century Pharmaceuticals Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.20.5 Century Pharmaceuticals Key News & Latest Developments
7.21 VETINDIA Pharmaceuticals
7.21.1 VETINDIA Pharmaceuticals Company Summary
7.21.2 VETINDIA Pharmaceuticals Business Overview
7.21.3 VETINDIA Pharmaceuticals Pet Disease Drugs Major Product Offerings
7.21.4 VETINDIA Pharmaceuticals Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.21.5 VETINDIA Pharmaceuticals Key News & Latest Developments
7.22 Ourofino Animal Health
7.22.1 Ourofino Animal Health Company Summary
7.22.2 Ourofino Animal Health Business Overview
7.22.3 Ourofino Animal Health Pet Disease Drugs Major Product Offerings
7.22.4 Ourofino Animal Health Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.22.5 Ourofino Animal Health Key News & Latest Developments
7.23 SeQuent Scientific
7.23.1 SeQuent Scientific Company Summary
7.23.2 SeQuent Scientific Business Overview
7.23.3 SeQuent Scientific Pet Disease Drugs Major Product Offerings
7.23.4 SeQuent Scientific Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.23.5 SeQuent Scientific Key News & Latest Developments
7.24 LABINDIA Healthcare
7.24.1 LABINDIA Healthcare Company Summary
7.24.2 LABINDIA Healthcare Business Overview
7.24.3 LABINDIA Healthcare Pet Disease Drugs Major Product Offerings
7.24.4 LABINDIA Healthcare Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.24.5 LABINDIA Healthcare Key News & Latest Developments
7.25 Morvel Laboratories
7.25.1 Morvel Laboratories Company Summary
7.25.2 Morvel Laboratories Business Overview
7.25.3 Morvel Laboratories Pet Disease Drugs Major Product Offerings
7.25.4 Morvel Laboratories Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.25.5 Morvel Laboratories Key News & Latest Developments
7.26 Richter Pharma
7.26.1 Richter Pharma Company Summary
7.26.2 Richter Pharma Business Overview
7.26.3 Richter Pharma Pet Disease Drugs Major Product Offerings
7.26.4 Richter Pharma Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.26.5 Richter Pharma Key News & Latest Developments
7.27 Zuche Pharmaceuticals
7.27.1 Zuche Pharmaceuticals Company Summary
7.27.2 Zuche Pharmaceuticals Business Overview
7.27.3 Zuche Pharmaceuticals Pet Disease Drugs Major Product Offerings
7.27.4 Zuche Pharmaceuticals Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.27.5 Zuche Pharmaceuticals Key News & Latest Developments
7.28 Fidelis Animal Health
7.28.1 Fidelis Animal Health Company Summary
7.28.2 Fidelis Animal Health Business Overview
7.28.3 Fidelis Animal Health Pet Disease Drugs Major Product Offerings
7.28.4 Fidelis Animal Health Pet Disease Drugs Sales and Revenue in Global (2019-2024)
7.28.5 Fidelis Animal Health Key News & Latest Developments
8 Global Pet Disease Drugs Production Capacity, Analysis
8.1 Global Pet Disease Drugs Production Capacity, 2019-2030
8.2 Pet Disease Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Pet Disease Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pet Disease Drugs Supply Chain Analysis
10.1 Pet Disease Drugs Industry Value Chain
10.2 Pet Disease Drugs Upstream Market
10.3 Pet Disease Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pet Disease Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Pet Disease Drugs in Global Market
Table 2. Top Pet Disease Drugs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Pet Disease Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Pet Disease Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Pet Disease Drugs Sales by Companies, (K Units), 2019-2024
Table 6. Global Pet Disease Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Pet Disease Drugs Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Pet Disease Drugs Product Type
Table 9. List of Global Tier 1 Pet Disease Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pet Disease Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Pet Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Pet Disease Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Pet Disease Drugs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Pet Disease Drugs Sales (K Units), 2019-2024
Table 15. By Type - Global Pet Disease Drugs Sales (K Units), 2025-2030
Table 16. By Application ? Global Pet Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Pet Disease Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Pet Disease Drugs Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Pet Disease Drugs Sales (K Units), 2019-2024
Table 20. By Application - Global Pet Disease Drugs Sales (K Units), 2025-2030
Table 21. By Region ? Global Pet Disease Drugs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Pet Disease Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Pet Disease Drugs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Pet Disease Drugs Sales (K Units), 2019-2024
Table 25. By Region - Global Pet Disease Drugs Sales (K Units), 2025-2030
Table 26. By Country - North America Pet Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Pet Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Pet Disease Drugs Sales, (K Units), 2019-2024
Table 29. By Country - North America Pet Disease Drugs Sales, (K Units), 2025-2030
Table 30. By Country - Europe Pet Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Pet Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Pet Disease Drugs Sales, (K Units), 2019-2024
Table 33. By Country - Europe Pet Disease Drugs Sales, (K Units), 2025-2030
Table 34. By Region - Asia Pet Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Pet Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Pet Disease Drugs Sales, (K Units), 2019-2024
Table 37. By Region - Asia Pet Disease Drugs Sales, (K Units), 2025-2030
Table 38. By Country - South America Pet Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Pet Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Pet Disease Drugs Sales, (K Units), 2019-2024
Table 41. By Country - South America Pet Disease Drugs Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Pet Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Pet Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Pet Disease Drugs Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Pet Disease Drugs Sales, (K Units), 2025-2030
Table 46. Merck & Co., Inc. Company Summary
Table 47. Merck & Co., Inc. Pet Disease Drugs Product Offerings
Table 48. Merck & Co., Inc. Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Merck & Co., Inc. Key News & Latest Developments
Table 50. Ceva Company Summary
Table 51. Ceva Pet Disease Drugs Product Offerings
Table 52. Ceva Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Ceva Key News & Latest Developments
Table 54. Vetoquinol S.A. Company Summary
Table 55. Vetoquinol S.A. Pet Disease Drugs Product Offerings
Table 56. Vetoquinol S.A. Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Vetoquinol S.A. Key News & Latest Developments
Table 58. Zoetis Company Summary
Table 59. Zoetis Pet Disease Drugs Product Offerings
Table 60. Zoetis Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Zoetis Key News & Latest Developments
Table 62. Virbac Company Summary
Table 63. Virbac Pet Disease Drugs Product Offerings
Table 64. Virbac Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Virbac Key News & Latest Developments
Table 66. Bimeda Company Summary
Table 67. Bimeda Pet Disease Drugs Product Offerings
Table 68. Bimeda Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Bimeda Key News & Latest Developments
Table 70. Calier Company Summary
Table 71. Calier Pet Disease Drugs Product Offerings
Table 72. Calier Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Calier Key News & Latest Developments
Table 74. Boehringer Ingelheim Company Summary
Table 75. Boehringer Ingelheim Pet Disease Drugs Product Offerings
Table 76. Boehringer Ingelheim Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Boehringer Ingelheim Key News & Latest Developments
Table 78. Elanco Animal Health Company Summary
Table 79. Elanco Animal Health Pet Disease Drugs Product Offerings
Table 80. Elanco Animal Health Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Elanco Animal Health Key News & Latest Developments
Table 82. Dechra Pharmaceuticals Company Summary
Table 83. Dechra Pharmaceuticals Pet Disease Drugs Product Offerings
Table 84. Dechra Pharmaceuticals Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Dechra Pharmaceuticals Key News & Latest Developments
Table 86. Norbrook Laboratories Company Summary
Table 87. Norbrook Laboratories Pet Disease Drugs Product Offerings
Table 88. Norbrook Laboratories Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Norbrook Laboratories Key News & Latest Developments
Table 90. Chanelle Pharma Company Summary
Table 91. Chanelle Pharma Pet Disease Drugs Product Offerings
Table 92. Chanelle Pharma Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Chanelle Pharma Key News & Latest Developments
Table 94. K-Laser USA Company Summary
Table 95. K-Laser USA Pet Disease Drugs Product Offerings
Table 96. K-Laser USA Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. K-Laser USA Key News & Latest Developments
Table 98. Assisi Animal Health Company Summary
Table 99. Assisi Animal Health Pet Disease Drugs Product Offerings
Table 100. Assisi Animal Health Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. Assisi Animal Health Key News & Latest Developments
Table 102. Multi Radiance Medical Company Summary
Table 103. Multi Radiance Medical Pet Disease Drugs Product Offerings
Table 104. Multi Radiance Medical Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 105. Multi Radiance Medical Key News & Latest Developments
Table 106. Avazzia Company Summary
Table 107. Avazzia Pet Disease Drugs Product Offerings
Table 108. Avazzia Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 109. Avazzia Key News & Latest Developments
Table 110. SOUND Technologies Company Summary
Table 111. SOUND Technologies Pet Disease Drugs Product Offerings
Table 112. SOUND Technologies Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 113. SOUND Technologies Key News & Latest Developments
Table 114. IRM Enterprises Company Summary
Table 115. IRM Enterprises Pet Disease Drugs Product Offerings
Table 116. IRM Enterprises Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 117. IRM Enterprises Key News & Latest Developments
Table 118. Ashish Life Science Company Summary
Table 119. Ashish Life Science Pet Disease Drugs Product Offerings
Table 120. Ashish Life Science Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 121. Ashish Life Science Key News & Latest Developments
Table 122. Century Pharmaceuticals Company Summary
Table 123. Century Pharmaceuticals Pet Disease Drugs Product Offerings
Table 124. Century Pharmaceuticals Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 125. Century Pharmaceuticals Key News & Latest Developments
Table 126. VETINDIA Pharmaceuticals Company Summary
Table 127. VETINDIA Pharmaceuticals Pet Disease Drugs Product Offerings
Table 128. VETINDIA Pharmaceuticals Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 129. VETINDIA Pharmaceuticals Key News & Latest Developments
Table 130. Ourofino Animal Health Company Summary
Table 131. Ourofino Animal Health Pet Disease Drugs Product Offerings
Table 132. Ourofino Animal Health Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 133. Ourofino Animal Health Key News & Latest Developments
Table 134. SeQuent Scientific Company Summary
Table 135. SeQuent Scientific Pet Disease Drugs Product Offerings
Table 136. SeQuent Scientific Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 137. SeQuent Scientific Key News & Latest Developments
Table 138. LABINDIA Healthcare Company Summary
Table 139. LABINDIA Healthcare Pet Disease Drugs Product Offerings
Table 140. LABINDIA Healthcare Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 141. LABINDIA Healthcare Key News & Latest Developments
Table 142. Morvel Laboratories Company Summary
Table 143. Morvel Laboratories Pet Disease Drugs Product Offerings
Table 144. Morvel Laboratories Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 145. Morvel Laboratories Key News & Latest Developments
Table 146. Richter Pharma Company Summary
Table 147. Richter Pharma Pet Disease Drugs Product Offerings
Table 148. Richter Pharma Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 149. Richter Pharma Key News & Latest Developments
Table 150. Zuche Pharmaceuticals Company Summary
Table 151. Zuche Pharmaceuticals Pet Disease Drugs Product Offerings
Table 152. Zuche Pharmaceuticals Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 153. Zuche Pharmaceuticals Key News & Latest Developments
Table 154. Fidelis Animal Health Company Summary
Table 155. Fidelis Animal Health Pet Disease Drugs Product Offerings
Table 156. Fidelis Animal Health Pet Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 157. Fidelis Animal Health Key News & Latest Developments
Table 158. Pet Disease Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 159. Global Pet Disease Drugs Capacity Market Share of Key Manufacturers, 2021-2024
Table 160. Global Pet Disease Drugs Production by Region, 2019-2024 (K Units)
Table 161. Global Pet Disease Drugs Production by Region, 2025-2030 (K Units)
Table 162. Pet Disease Drugs Market Opportunities & Trends in Global Market
Table 163. Pet Disease Drugs Market Drivers in Global Market
Table 164. Pet Disease Drugs Market Restraints in Global Market
Table 165. Pet Disease Drugs Raw Materials
Table 166. Pet Disease Drugs Raw Materials Suppliers in Global Market
Table 167. Typical Pet Disease Drugs Downstream
Table 168. Pet Disease Drugs Downstream Clients in Global Market
Table 169. Pet Disease Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pet Disease Drugs Segment by Type in 2023
Figure 2. Pet Disease Drugs Segment by Application in 2023
Figure 3. Global Pet Disease Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Pet Disease Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Pet Disease Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. Pet Disease Drugs Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Pet Disease Drugs Revenue in 2023
Figure 9. By Type - Global Pet Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Pet Disease Drugs Revenue Market Share, 2019-2030
Figure 11. By Type - Global Pet Disease Drugs Sales Market Share, 2019-2030
Figure 12. By Type - Global Pet Disease Drugs Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Pet Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Pet Disease Drugs Revenue Market Share, 2019-2030
Figure 15. By Application - Global Pet Disease Drugs Sales Market Share, 2019-2030
Figure 16. By Application - Global Pet Disease Drugs Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Pet Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Pet Disease Drugs Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Pet Disease Drugs Revenue Market Share, 2019-2030
Figure 20. By Region - Global Pet Disease Drugs Sales Market Share, 2019-2030
Figure 21. By Country - North America Pet Disease Drugs Revenue Market Share, 2019-2030
Figure 22. By Country - North America Pet Disease Drugs Sales Market Share, 2019-2030
Figure 23. US Pet Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Pet Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Pet Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Pet Disease Drugs Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Pet Disease Drugs Sales Market Share, 2019-2030
Figure 28. Germany Pet Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. France Pet Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Pet Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Pet Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Pet Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Pet Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Pet Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Pet Disease Drugs Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Pet Disease Drugs Sales Market Share, 2019-2030
Figure 37. China Pet Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Pet Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Pet Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Pet Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. India Pet Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Pet Disease Drugs Revenue Market Share, 2019-2030
Figure 43. By Country - South America Pet Disease Drugs Sales Market Share, 2019-2030
Figure 44. Brazil Pet Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Pet Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Pet Disease Drugs Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Pet Disease Drugs Sales Market Share, 2019-2030
Figure 48. Turkey Pet Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Pet Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Pet Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Pet Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 52. Global Pet Disease Drugs Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Pet Disease Drugs by Region, 2023 VS 2030
Figure 54. Pet Disease Drugs Industry Value Chain
Figure 55. Marketing Channels
